Surgery Partners, Inc. reports developments tied to its short-stay surgical facility network and outpatient delivery model. The company provides surgical and related ancillary care through ambulatory surgery centers, surgical hospitals, anesthesia services, multi-specialty physician practices and urgent care facilities, with revenue tied to patient care services and facility case activity.
Recurring SGRY news includes quarterly results, same-facility revenue and case trends, adjusted EBITDA and guidance, operational initiatives, portfolio optimization, acquisition activity, financing and leverage actions, share repurchase authorizations, board composition and shareholder communications involving the company’s strategic direction.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Surgery Partners (NASDAQ:SGRY) will release its first quarter 2023 results on May 1, 2023, after market close. A conference call is scheduled for the same day at 5:00 p.m. ET. Interested parties can participate via a dial-in number or by accessing a live webcast on the Company's Investor Relations website. Surgery Partners is a prominent healthcare services provider, specializing in outpatient surgical care with over 180 locations across 31 states. The company aims to deliver high-quality, cost-effective solutions in surgical and related ancillary care.
Surgery Partners (SGRY) reported a revenue increase of 15.9% to $707.1 million for Q4 2022 and 14.1% to $2.5 billion for the full year. Despite strong revenue growth, the company faced a net loss of $23.4 million for Q4 2022 and $54.6 million for the full year. Adjusted EBITDA rose by 5.6% to $120.8 million in Q4 and 12.0% to $380.2 million for the full year. The company anticipates 2023 revenues greater than $2.75 billion and Adjusted EBITDA exceeding $425 million.